CX Institutional boosted its position in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) by 61.8% in the fourth quarter, Holdings Channel.com reports. The firm owned 115,677 shares of the company’s stock after acquiring an additional 44,172 shares during the period. CX Institutional’s holdings in Procter & Gamble were worth $16,578,000 as of its most recent SEC filing.
Other large investors have also added to or reduced their stakes in the company. Maseco LLP acquired a new stake in Procter & Gamble during the 4th quarter valued at $28,000. Saranac Partners Ltd acquired a new stake in Procter & Gamble during the 3rd quarter valued at $30,000. Corundum Trust Company INC acquired a new stake in Procter & Gamble during the 3rd quarter valued at $32,000. Caitlin John LLC acquired a new stake in Procter & Gamble during the 3rd quarter valued at $34,000. Finally, Marquette Asset Management LLC acquired a new stake in Procter & Gamble during the 3rd quarter valued at $37,000. 65.77% of the stock is owned by institutional investors and hedge funds.
Insiders Place Their Bets
In other news, insider Moses Victor Javier Aguilar sold 15,169 shares of Procter & Gamble stock in a transaction dated Friday, February 13th. The shares were sold at an average price of $162.28, for a total value of $2,461,625.32. Following the completion of the transaction, the insider directly owned 44,735 shares of the company’s stock, valued at approximately $7,259,595.80. The trade was a 25.32% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Chairman Jon R. Moeller sold 162,232 shares of Procter & Gamble stock in a transaction dated Thursday, February 12th. The shares were sold at an average price of $162.45, for a total transaction of $26,354,588.40. Following the completion of the transaction, the chairman directly owned 319,385 shares of the company’s stock, valued at $51,884,093.25. This trade represents a 33.68% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last three months, insiders sold 252,715 shares of company stock worth $40,966,904. Corporate insiders own 0.20% of the company’s stock.
Procter & Gamble Price Performance
Procter & Gamble (NYSE:PG – Get Free Report) last announced its quarterly earnings data on Friday, April 24th. The company reported $1.59 earnings per share for the quarter, topping the consensus estimate of $1.56 by $0.03. The company had revenue of $21.24 billion during the quarter, compared to analyst estimates of $21.52 billion. Procter & Gamble had a net margin of 19.16% and a return on equity of 32.00%. The firm’s revenue for the quarter was up 7.4% compared to the same quarter last year. During the same period last year, the business earned $1.54 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, research analysts anticipate that Procter & Gamble Company will post 6.92 earnings per share for the current fiscal year.
Procter & Gamble Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Friday, April 24th will be issued a $1.0885 dividend. This is a boost from Procter & Gamble’s previous quarterly dividend of $1.06. The ex-dividend date of this dividend is Friday, April 24th. This represents a $4.35 annualized dividend and a dividend yield of 3.0%. Procter & Gamble’s dividend payout ratio (DPR) is presently 63.60%.
Analysts Set New Price Targets
A number of equities research analysts recently weighed in on the stock. Jefferies Financial Group lowered their price target on shares of Procter & Gamble from $179.00 to $175.00 and set a “buy” rating for the company in a report on Monday, April 20th. Piper Sandler raised their price target on shares of Procter & Gamble from $142.00 to $145.00 and gave the company a “neutral” rating in a report on Friday, April 24th. Morgan Stanley lowered their price target on shares of Procter & Gamble from $175.00 to $166.00 and set an “overweight” rating for the company in a report on Wednesday, April 22nd. JPMorgan Chase & Co. lowered their price target on shares of Procter & Gamble from $165.00 to $162.00 and set an “overweight” rating for the company in a report on Friday, April 17th. Finally, The Goldman Sachs Group decreased their price objective on shares of Procter & Gamble from $159.00 to $155.00 and set a “neutral” rating for the company in a report on Wednesday, April 8th. Eleven analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $161.06.
Get Our Latest Stock Analysis on Procter & Gamble
About Procter & Gamble
Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Further Reading
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
